Bookmarks

The evidence-based management of pre-eclampsia and eclampsia
is an interactive, e-learning course for health professionals that was developed by clinicians at the University of Oxford. The course is available in English and Spanish through the Geneva Foundation for Medical Education and Research (GFMER) at http://www.gfmer.ch/SRH-Course-2010/pre-eclampsia-University-of-Oxford/index.htm.

The aim of the course is to familiarize participants with the most up-to-date, evidence-based, principles determining how pre-eclampsia and eclampsia should be managed. There are two versions: Basic for healthcare professionals who want to know/revise the fundamentals, and Advanced for doctors, midwives and nurses who want to know the evidence behind the recommendations.

Following successful completion of the course, participants may take a knowledge assessment test. Those who correctly answer at least 15 of the 20 MCQs are entitled to a course certificate jointly signed by the Nuffield Department of Obstetrics & Gynaecology at the University of Oxford and GFMER.

HIFA2015 is a campaign and knowledge network with more than 4000 members representing 1800 organisations in 157 countries worldwide. Members include health workers, publishers, librarians, information technologists, researchers, social scientists, journalists, policy-makers and others – all working together towards the HIFA2015 goal.

HIFA2015 contributes to the broader goal of the Global Health Workforce Alliance: ‘All people everywhere will have access to a skilled, motivated and supported health worker, within a robust health system’

Researchers from low and middle income countries (LMICs) are invited to apply for the fourth round of the WHO/TDR Career Development Fellowship (CDF) on clinical research & development (clinical R&D). Successful candidates will be placed with leading product development institutions, including pharmaceutical companies that are participating in the fellowship programme (“host institutions”). The goal is to develop human resources to promote high quality clinical R&D in LMICs. It is expected that qualified professionals will enhance LMICs’ product development capacity on diagnostics, drugs and vaccines for infectious diseases that disproportionately affect poor and marginalized populations.
The host institutions will train individuals in situ in order to develop specialized skills not readily taught in academic centres, including R&D project management, regulatory requirements and good health research practices. On returning to their home institutions, the fellows are expected to become an important resource for institutional capacity development to undertake and manage clinical research in accordance with international regulatory requirements and standards.

All applications must be received by 7th October 2012 at the latest.